Still too many unknowns for me. I come out thinking the risk is...

Still too many unknowns for me. I come out thinking the risk is greater than ever.

US BP has one eye on open re funding.

Understands it’s near impossible to raise in current market and keep value.

Reliance on CCP bodies to get this over the line?

TGA a slowburn

Absolute dosing mess due to a rat

Overly waffly from PR bordering on unprofessional at times. Dropped the ball on one word “we have tried to….” Maybe looking for “improve”?

Thank the team once and press on.

CLearly strategy chops and changes on any new piece of info. No “laser focus”

Won’t be selling based on the drug, equally won’t be buying based on team’s ability to execute.

These were my notes on the fly.